STABLE HIGH STRENGTH PHARMACEUTICAL COMPOSITION OF LEVOLEUCOVORIN

STABLE HIGH STRENGTH PHARMACEUTICAL COMPOSITION OF LEVOLEUCOVORIN

The administration of levoleucovorin is useful as an antidote to drugs which act as folic acid antagonists and in combination chemotherapy with 5-FU . The most often used calcium salts of levoleucovorin have a limited solubility in water. Therefore aqueous solutions are unstable and precipitates are...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: ULMANN, Martin
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ULMANN, Martin
description The administration of levoleucovorin is useful as an antidote to drugs which act as folic acid antagonists and in combination chemotherapy with 5-FU . The most often used calcium salts of levoleucovorin have a limited solubility in water. Therefore aqueous solutions are unstable and precipitates are resulting. Precipitates in injectable products present an unacceptable risk to patients. Stable high strength pharmaceutical aqueous compositions containing calcium salts, magnesium or zinc salts of levoleucovorin and one or more of the compounds sodium gluconate, potassium gluconate, magnesium gluconate, calcium gluconate, sodium lactate, potassium lactate, magnesium lactate, calcium lactate, glycerophosphate disodium salt, glycerophosphate dipotassium salt glycerophosphate calcium salt or glycerophosphate magnesium salt are disclosed.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP2991618B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP2991618B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP2991618B13</originalsourceid><addsrcrecordid>eNrjZHAMDnF08nFV8PB091AIDgly9XMP8VAI8HAM8nV0dg0N8XR29FFw9vcN8A_2DPH091Pwd1PwcQ3z93ENdfYP8w_y9ONhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuAUaWloZmhhZOhsZEKAEAsOgrDA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>STABLE HIGH STRENGTH PHARMACEUTICAL COMPOSITION OF LEVOLEUCOVORIN</title><source>esp@cenet</source><creator>ULMANN, Martin</creator><creatorcontrib>ULMANN, Martin</creatorcontrib><description>The administration of levoleucovorin is useful as an antidote to drugs which act as folic acid antagonists and in combination chemotherapy with 5-FU . The most often used calcium salts of levoleucovorin have a limited solubility in water. Therefore aqueous solutions are unstable and precipitates are resulting. Precipitates in injectable products present an unacceptable risk to patients. Stable high strength pharmaceutical aqueous compositions containing calcium salts, magnesium or zinc salts of levoleucovorin and one or more of the compounds sodium gluconate, potassium gluconate, magnesium gluconate, calcium gluconate, sodium lactate, potassium lactate, magnesium lactate, calcium lactate, glycerophosphate disodium salt, glycerophosphate dipotassium salt glycerophosphate calcium salt or glycerophosphate magnesium salt are disclosed.</description><language>eng ; fre ; ger</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190109&amp;DB=EPODOC&amp;CC=EP&amp;NR=2991618B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76318</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20190109&amp;DB=EPODOC&amp;CC=EP&amp;NR=2991618B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ULMANN, Martin</creatorcontrib><title>STABLE HIGH STRENGTH PHARMACEUTICAL COMPOSITION OF LEVOLEUCOVORIN</title><description>The administration of levoleucovorin is useful as an antidote to drugs which act as folic acid antagonists and in combination chemotherapy with 5-FU . The most often used calcium salts of levoleucovorin have a limited solubility in water. Therefore aqueous solutions are unstable and precipitates are resulting. Precipitates in injectable products present an unacceptable risk to patients. Stable high strength pharmaceutical aqueous compositions containing calcium salts, magnesium or zinc salts of levoleucovorin and one or more of the compounds sodium gluconate, potassium gluconate, magnesium gluconate, calcium gluconate, sodium lactate, potassium lactate, magnesium lactate, calcium lactate, glycerophosphate disodium salt, glycerophosphate dipotassium salt glycerophosphate calcium salt or glycerophosphate magnesium salt are disclosed.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHAMDnF08nFV8PB091AIDgly9XMP8VAI8HAM8nV0dg0N8XR29FFw9vcN8A_2DPH091Pwd1PwcQ3z93ENdfYP8w_y9ONhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfGuAUaWloZmhhZOhsZEKAEAsOgrDA</recordid><startdate>20190109</startdate><enddate>20190109</enddate><creator>ULMANN, Martin</creator><scope>EVB</scope></search><sort><creationdate>20190109</creationdate><title>STABLE HIGH STRENGTH PHARMACEUTICAL COMPOSITION OF LEVOLEUCOVORIN</title><author>ULMANN, Martin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP2991618B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2019</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>ULMANN, Martin</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ULMANN, Martin</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>STABLE HIGH STRENGTH PHARMACEUTICAL COMPOSITION OF LEVOLEUCOVORIN</title><date>2019-01-09</date><risdate>2019</risdate><abstract>The administration of levoleucovorin is useful as an antidote to drugs which act as folic acid antagonists and in combination chemotherapy with 5-FU . The most often used calcium salts of levoleucovorin have a limited solubility in water. Therefore aqueous solutions are unstable and precipitates are resulting. Precipitates in injectable products present an unacceptable risk to patients. Stable high strength pharmaceutical aqueous compositions containing calcium salts, magnesium or zinc salts of levoleucovorin and one or more of the compounds sodium gluconate, potassium gluconate, magnesium gluconate, calcium gluconate, sodium lactate, potassium lactate, magnesium lactate, calcium lactate, glycerophosphate disodium salt, glycerophosphate dipotassium salt glycerophosphate calcium salt or glycerophosphate magnesium salt are disclosed.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP2991618B1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title STABLE HIGH STRENGTH PHARMACEUTICAL COMPOSITION OF LEVOLEUCOVORIN
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T05%3A49%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ULMANN,%20Martin&rft.date=2019-01-09&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP2991618B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true